Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol to Reduce Left Ventricular Mass in Living Kidney Donors
NCT03353298Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in left ventricular hypertrophy (LVH), sponsored by Oslo University Hospital. Started Jan 2018; status: completed.
02
Drugs
allopurinol
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT03353298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353298.